Clinical Trial Update: Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration [NA]

View source ↗

Summary

A clinical study evaluating continuous glucose sensing at the site of subcutaneous insulin administration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Medical University of Graz | Conditions: Type 1 Diabetes | NA | Status: COMPLETED